期刊文献+

皮质基底节变性患者的蛋白质组研究 被引量:3

A proteomics study of patients with corticobasal degeneration
原文传递
导出
摘要 目的 探讨皮质基底节变性的分子机制并寻找诊断治疗该疾病的蛋白质标记物.方法 尸检来自解放军总医院死亡24 h内、经病理证实的男性皮质基底节变性患者(4例)脑及无神经系统疾患的正常老年男性(4例)脑组织,额叶、颞叶和纹状体部位取材,应用HE染色、Gallyas-Braak银染色和Tau蛋白免疫组织化学染色观察皮质基底节变性患者的脑组织学改变;额叶部位取材,以固相pH梯度等电聚焦为第一向,SDS-聚丙烯酰胺凝胶电泳(SDS-PAGE)电泳为第二向进行双向电泳,分析电泳图谱后采用MALDI-TOFTOF串联质谱仪进行蛋白质的鉴定.结果 HE染色显示皮质基底节变性患者额叶神经元明显脱失,伴胶质细胞大量增生,Gallyas-Braak和Tau免疫组化染色结果显示纹状体中大量球形团样缠结;与正常老年人脑组织比较,皮质基底节变性患者脑组织9个蛋白表达增加(经鉴定为coflin、尿嘧啶DNA糖苷水解酶、Cu-Zn超氧化物歧化酶、异柠檬酸脱氢酶亚单位、突触结合蛋白Ⅰ、硫氧还蛋白过氧化物酶1、胶质纤维酸性蛋白、P25alpha、Peroxircdoxin 5),5个蛋白表达下降(经鉴定为碳酰还原酶[NADPH]1、铁蛋白H链、肽基脯氨酸顺反异构酶A、血清白蛋白前体、二氢嘧啶酶相关蛋白2),差异有统计学意义(P<0.05).结论 上述差异蛋白有助于探讨皮质基底节变性的分子机制及其早期诊断和新药开发. Objective To investigate the molecular mechanism of corticobasal degeneration and search the protein markers ofdiagnoseis and treatment of this disease. Methods The brains of subjects died without clinical or pathological involvement of nervous system (n=4) and brains of patients with corticobasal degeneration (n=4) were obtained at autopsy. Tissues samples were cut from the frontal and temporal lobes, and the striatum. Histological changes of the tissue samples were observed by HE staining, Gallyas-Braak silver staining and Tau protein immunohistochemistry. The samples extracted from the frontal lobe were performed dimensional electrophoresis with immobilized pH gradient (IPG)isoelectric focusing electrophoresis as the first dimension and with vertical sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) as the second dimension; the maps were visualized by Coomassie brilliant blue staining and analyzed with ImageMaster 2D Elite software; the protein profiles were in-gel digested and identified by mass spectrometry (MALDI-TOFTOF). Results Significant neuron loss in the temporal lobe of patients with corticobasal degeneration was noted by HE staining, with mass proliferation of gliocyte in the temporal lobe; sphere-like entanglement in the striatum was noted by Gallyas-Braak silver staining and Tau immunohistochemistry. Fourteen protein spots in the brains of patients with corticobasal degeneration were differentially expressed as compared with those in age-matched nondemented control brains; the expression of 9 proteins (cofilin, uracil DNA glycosylase,Cu-Zn superoxide dismutase, isocitrate dehydrogenase subunit, synaptotagmin Ⅰ, thioredoxin peroxidase 1, glial fibrillary acidic protein, P25 alpha and peroxiredoxin 5) in brains of patients with corticobasal degeneration was up-regulated as compared with that in the normal brain tissue (P〈0.05); the expression of 5 proteins (carbonyl reductase [NADPH] 1, ferritin heavy chain, peptidyl-prolyl cis-trans isomerase A,serum albumin precursor and dihydropyrimidinase-related protein 2) in brains of patients with corticobasal degeneration was down-regulated as compared with that in the normal brain tissues (P〈0.05).Conclusion We get a number of related-proteins of corticobasal degeneration. Some proteins are quite useful in discovering the molecular mechanisms of corticobasal degeneration and may be helpful in the ealry diagnosis and treatment of corticobasal degeneration and in the development of new medicine.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2011年第1期15-18,共4页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(30500164) 河北省自然科学基金(C2007000848) 河北省科技研发指令计划项目(06276102D-99)
关键词 蛋白质组学 电泳 凝胶 双向 皮质基底节变性 Proteomics Electrophoresis, gel, two-dimensional Corticobasal degeneration
  • 相关文献

参考文献13

  • 1Rhein V,Song X,Wiesner A,et al.Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice[J].Proc Natl Acad Sci U S A,2009,106(47):20057-2062.
  • 2Butterfield DA,Lange ML.Multifunctional roles of enolase in Alzheimer's disease brain:beyond altered glucose metabolism[J].J Neurochem,2009,11(4):915-933.
  • 3Gozal YM,Duong DM,Gearing M,et al.Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease[J].J Proteome Res,2009,8(11):5069-5079.
  • 4黎凯锋,吴多斌,高筱雅,刘亚杰,刘振华.CYP19基因多态性与阿尔茨海默病遗传易感性的相关性研究[J].中华神经医学杂志,2009,8(1):2-4. 被引量:1
  • 5赵燕星,林琳,苏殿三,陈杰,王祥瑞.阿尔茨海默病APPswe/PS1dE9双转基因小鼠对挥发性吸入麻醉药药物敏感性的变化[J].实用医学杂志,2010,26(5):735-737. 被引量:6
  • 6Chen W,Ji J,Ru B,et al.Proteomic analysis of corticobasal degeneration:a case study of corticobasal degeneration at the proteome level[J].J Neuropsychiatry Clin Neurosci,2005,17(3):364-371.
  • 7朱明伟,王鲁宁,张笑明.Gallyas-Braak银染色方法在神经组织病变中的应用[J].中华病理学杂志,2001,30(5):384-385. 被引量:6
  • 8Pfaendtner J,De La,Cruz EM.Actin filament remodeling by actin depolymerization factor/cofilin[J].Proc Natl Acad Sci USA,2010,107(16):239-254.
  • 9David Muyllaert,Dick Terwel.Anna kremer neurodegeneration and neuroinflammation in cdk5/p25-inducible mice:a model for hippocampal sclerosis and neocortical degeneration[J].Am J Pathol,2008,172(2):470-485.
  • 10Radyuk SN,Michalak K,Klichko VI,et al.Peroxiredoxin 5 confers protection against oxidative stress and apoptosis and also promotes longevity in Drosophila[J].Biochem J,2009,419(2):437-445.

二级参考文献22

  • 1欧阳晓春,刘振华,吴多斌,谭盛.N-乙酰基转移酶基因多态性与老年性痴呆的关系[J].中国临床康复,2005,9(41):20-22. 被引量:2
  • 2沈凌,李占魁.脑芳香化酶的表达特点及其生物学意义[J].实用儿科临床杂志,2006,21(22):1586-1588. 被引量:6
  • 3Trainor BC, Kyomen HH, Marler CA. Estrogenic encounters :How interactions between aromatase and environment modulate aggression[J]. Frontiers Neuroendoci, 2006, 27(2): 170-179.
  • 4Oteiza PI. A mechanism for the stimulatory effect of aluminum on iron-induced lipid peroxidation[J]. Arch Biochem Biophys, 1994, 308: 374-379.
  • 5Hardad N, Yamada K, Saito K, et al. Structrual characterization of the human estrogen syntheatse (aromatase) gene [J]. Biochem Biophys Res Commun, 1990, 166(1): 365.
  • 6Katsumi T, Satoshi N, Yutakaas S. Identification and characterizatioon of transcriptional regulatory elements of the human aromatase cytochrome P450 gene [J]. J Steroid Biochem Molec Biol, 1996, 56(1): 151.
  • 7Kilgore MW, Means GD, Mendelson CR, et al. Altermative promotion of aromatase cytochrome P450 expression in human fetal tissues[J]. Mol Cell Endocrinol, 1992, 83: 9.
  • 8Hiltunen M, Mannermaa A, Thompson D, et al. Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland[J]. Neurology, 2001, 57: 1663-1668.
  • 9Huang R , Poduslo SE. CYP19 haplotypes increase risk for Alzheimer's disease[J]. J Med Genet, 2006, 43: 42.
  • 10Aruoma O I, Jen S S, Watts H R, et al. Acute and chronic effects of intravitreally injected beta-amyloid on the neurotransmitter system in the retina [ J ]. Toxicology, 2009,256 ( 1-2 ) : 92-100.

共引文献10

同被引文献42

  • 1Li J,Scheller C,Koutsilieri E,et al.Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells[J].J Neurochem,2005,95(2):599-608.
  • 2Ben-Shachar D,Riederer P,Youdim MB,et al.Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease[J].J Neurochem,1991,57(5):1609-1614.
  • 3Koziorowski D,Friedman A,Arosio P,et al.ELISA reveals a difference in the structure of substantia nigra ferrition in Parkinson's disease and incidental Lewy body compared to control[J].Parkinsonism Relat Disord,2007,13(4):214-218.
  • 4Galazka-Friedman J,Bauminger ER,Koziorowski D,et al.Mossbauer spectroscopy and ELISA studies reveal differences between Parkinson diseases and control substantia nigra[J].Biochim Biophys Acta,2004,1688(2):130-136.
  • 5Dexter DT,Carayon A,Javoy-Agid,et al.Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia[J].Ann Neurol,1994,36(3):348-355.
  • 6Faucheux BA,Damier P,Spik G.Lack of upregulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients of Parkinson's disease[J]. J Neurochem,2002,83(2):320-330.
  • 7Griffiths PD,Dobson BR,Jones GR,et al.Iron in the basal ganglia in Parkinson's disease:an in vitro using x-ray absorption fine structure and cyro-electron microscopy[J].Brain,1999,122(Pt 4):667-673.
  • 8Rego AC,Oliveira CR.Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis:implications for the pathogenesis ofneurodegenerative diseases[J].Neurochem Res,2003,28(10):1563-1574.
  • 9Rouault TA.Iron on the brain[J].Nat G-enet,2001,28:99-300.
  • 10Ke Y,MingQian Z.Iron misregulation in the brain:a primary cause ofneurodegenerativediscords[J].Lancet Neurol,2003,2 (4):246-253.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部